Page 47 - Live-cellanalysis handbook
P. 47

Kinetic Cell Migration and Invasion Assays


           How Live-Cell Migration and Invasion Assays Work

           IncuCyte® Scratch Wound Assay                          IncuCyte® Chemotaxis Assay

           The IncuCyte Scratch Wound Assay is a 96-well, high throughput   The IncuCyte Chemotaxis Assay enables real-time visualization
           wound assay that measures cell density-dependent migration and   and quantification of cell migration and invasion in response to
           invasion. Utilizing the IncuCyte® WoundMaker, 96 precise, uniform,   a chemotactic gradient. Using an optically clear membrane insert
           cell-free zones are created in cell monolayers and wound closure   that contains optimally spaced 8-micron pores, cell migration and
           is visualized and analyzed in real-time with the IncuCyte® live-cell   invasion are automatically imaged and analyzed as the cells move
           analysis system and software.                          through the pores, generating a chemotactic signal.




           References


           1.   Cell Migration: integrating signals from front to back. Ridley, A.J., Schwartz, M.A., Burridge, K., Firtel, R.A., Ginsberg, M.H., Borisy, G., Parsons. J.T. and
               Horwitz, A.R. Science 302: 1704.
           2.   Cell Migration and Invasion Assays as Tools for Drug Discovery. Hulkower, K. I and Herber, R. L. Pharmaceutics 2011 3:107


           Recent IncuCyte® Publications

           Scratch wound assay

           Drebert, et. al., used the IncuCyte scratch wound assay to assess HUVEC migration in response to conditioned medium from solvent- (CMS)
           and dexamethasone (Dex)-treated (CMD) colon cancer-derived myofibroblasts.  In the HUVEC scratch assay CMS-induced acceleration of
           wound healing was blunted by CMD treatment.

           Colon cancer-derived myofibroblasts increase endothelial cell migration by glucocorticoid-sensitive secretion of a pro-migratory factor. Drebert, Z., MacAskill,
           M., Doughty-Shenton, D., De Bosscher, K., Bracke, M., Hadoke, P. W., Beck, I. M.  Vascul. Pharmacol., Vascul Pharmacol. 2016 Oct 4. pii: S1537-1891(16)30137-9.
           doi: 10.1016/j.vph.2016.10.004. [Epub ahead of print], 2017.

           Härmä, et. al., cultured prostate cancer cells on ImageLock plates from Essen BioScience until fully confluent and scratched with the
           WoundMaker instrument. Wound closure was monitored and quantified with the IncuCyte® system. Study results suggest that some
           betulin-derivatives may specifically target cell motility and invasion by affecting the organization of filamentous actin fiber network at
           low nanomolar concentrations.

           Optimization of invasion-specific effects of betulin derivatives on prostate cancer cells through lead development. Härmä, V., Haavikko, R., Virtanen,
           J., Ahonen, I., Schukov, H. P., Alakurtti, S., Purev, E., Rischer, H., Yli-Kauhaluoma, J., Moreira, V. M., Nees, M., Oksman-Caldentey, K. M.  PLoS ONE 05/2015
           10(5):e0126111.


           Moody, et. al. conducted scratch wound assays using the IncuCyte platform to assess the functional consequence of growth arrest specific
           6 (Gas6) neutralization in lung cancer cells.  Gas6 is a vitamin-K dependent, 75 kDa growth factor-like protein involved in the regulation
           of a wide array of cellular activities, including adhesion, migration, mitogenesis, aggregation, stress-response, differentiation, immune
           activation, efferocytosis and apoptosis. A Gas6 neutralizing antibody was also tested for its ability to inhibit Gas6-induced proliferation
           using the same platform.

           Antibody-mediated neutralization of autocrine Gas6 inhibits the growth of pancreatic ductal adenocarcinoma tumors in vivo. Moody, G., Belmontes,
           B., Masterman, S., Wang, W., King, C., Murawsky, C., Tsurda, T., Liu, S., Radinsky, R., Beltran, P. Int J of Cancer. 2016 139:1340.



           This review article explores how advances in time-resolved imaging contributes to the characterization of distinct modes of invasion and
           molecular mechanisms. The author highlights the latest advances in kinetic imaging instrumentation applicable to in vitro and in vivo
           models of tumor invasion.

           Profiling distinct mechanisms of tumor invasion for drug discovery: imaging adhesion, signalling and matrix turnover. Carragher, N. Clinical & Exp
           Metastasis. 2009 April 26(4).




                                                                                                                    45
   42   43   44   45   46   47   48   49   50   51   52